Stay updated with breaking news from Formp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $2.48 and traded as low as $2.25. Oramed Pharmaceuticals shares last traded at $2.34, with a volume of 44,022 shares. Oramed Pharmaceuticals […]
Rathbones Group PLC bought a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 289,803 shares of the biotechnology company’s stock, valued at approximately $756,000. Rathbones Group PLC owned approximately 0.72% […]
N.E.W. Advisory Services LLC acquired a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 12,960 shares of the biotechnology company’s stock, valued at approximately $34,000. A number of other large investors also recently added to […]
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.61 and traded as low as $2.17. Oramed Pharmaceuticals shares last traded at $2.23, with a volume of 80,966 shares. Analyst Ratings Changes Separately, StockNews.com began coverage on […]
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.66 and traded as low as $2.21. Oramed Pharmaceuticals shares last traded at $2.32, with a volume of 161,057 shares traded. Wall Street Analysts Forecast Growth […]